Oragenics, Inc.
OGEN
$0.183
$0.0084.57%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | 0.00 | 7.50K | 20.70K | 37.70K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 0.00 | 7.50K | 20.70K | 37.70K |
| Cost of Revenue | 4.11M | 13.49M | 13.38M | 14.48M | 15.49M |
| Gross Profit | -4.11M | -13.49M | -13.37M | -14.46M | -15.45M |
| SG&A Expenses | 6.44M | 6.51M | 6.28M | 6.00M | 5.45M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.56M | 20.00M | 19.66M | 20.48M | 20.94M |
| Operating Income | -10.56M | -20.00M | -19.66M | -20.46M | -20.90M |
| Income Before Tax | -10.57M | -19.97M | -19.52M | -20.26M | -20.66M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.57 | -19.97 | -19.52 | -20.26 | -20.66 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.57M | -19.97M | -19.52M | -20.26M | -20.66M |
| EBIT | -10.56M | -20.00M | -19.66M | -20.46M | -20.90M |
| EBITDA | -10.53M | -19.98M | -19.64M | -20.44M | -20.88M |
| EPS Basic | -1.87 | -6.51 | -6.99 | -7.98 | -8.69 |
| Normalized Basic EPS | -1.17 | -4.07 | -4.37 | -4.99 | -5.43 |
| EPS Diluted | -1.87 | -6.51 | -6.99 | -7.98 | -8.69 |
| Normalized Diluted EPS | -1.17 | -4.07 | -4.37 | -4.99 | -5.43 |
| Average Basic Shares Outstanding | 26.47M | 17.14M | 12.97M | 10.47M | 8.99M |
| Average Diluted Shares Outstanding | 26.47M | 17.14M | 12.97M | 10.47M | 8.99M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |